3-methyl-3-pyrrolidinecarboxylic acid, 95.0%, 250mg

N-(4-cyanophenyl)methanesulfonamide, 97.0%, 10g

Ethyl 4,6-dichloro-1H-indole-2-carboxylate, 97.0%, 10g

4,4,5,5-Tetramethyl-2-(4-(4-(trifluoromethyl)phenoxy)phenyl)-1,3,2-dioxaborolane, 250mg

{2-methanesulfonyl-1-[3-(propan-2-yloxy)propyl]-1H-imidazol-5-yl}methanol, 95.0%, 2g

5-Fluoro-4-methyl-1H-indazole, 95.0%, 5g

1,8-Diazaspiro[4.5]decane-2,4-dione hydrochloride, 95%, 1g

3-[4-(Methylsulfonyl)phenyl]-5-(1-boc-4-piperidyl)-1,2,4-oxadiazole, 97.0%, 10g

4-AMINO-2,2-DIFLUOROBUTANOIC ACID HCL, 95%, 1g

2-Chloro-6-(trifluoromethyl)nicotinic Acid>98.0%(T)1g

[(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4',5'-d]pyran-3a-yl]methyl sulfamate, 98.0%, 5g

1-(3-chlorophenyl)ethan-1-ol, 97.0%, 500g

Colonna HPLC NUCLEODUR® C8 Gravity 3 µm, 250 mm, 4 mm, 1 Pezzo(i)